TDC
AUGX

Thompson Davis & Co’s Augmedix, Inc. Common Stock AUGX Stock Holding History

Thompson Davis & Co’s Portfolio AUGX Stock Details AUGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-20,500
Closed -$120K – 143
2023
Q4 		$120K Buy
+20,500
New +$108K 0.1% 84

Other funds holding AUGX

RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
SM
Samjo Management New York $231M AUM 13.04% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
PCM
Perkins Capital Management Wayzata, Minnesota $107M AUM 82.62% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
PHP
Parkman Healthcare Partners Stamford, Connecticut $970M AUM 79.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
RPAM
Rhenman & Partners Asset Management Stockholm, Sweden $810M AUM 30.2% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return

Thompson Davis & Co's AUGX Position: Q1 2024 in Review

Thompson Davis & Co sold out of Augmedix, Inc. Common Stock (AUGX) in Q1 2024, closing a stake of 20,500 shares — an estimated $120K sold.

Thompson Davis & Co first reported a position in AUGX in Q4 2023 and held it in 1 quarter. The position peaked at $120K in Q4 2023. 84 funds tracked by Wall St. Rank hold AUGX as of Q1 2024.

  • Thompson Davis & Co reported no remaining Augmedix, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • Thompson Davis & Co sold 20,500 Augmedix, Inc. Common Stock shares in Q1 2024, an estimated $120K.
  • Thompson Davis & Co first reported a position in Augmedix, Inc. Common Stock in Q4 2023 and held it in 1 quarter.
  • Thompson Davis & Co's Augmedix, Inc. Common Stock position peaked at $120K in Q4 2023.
  • 84 funds tracked by Wall St. Rank held Augmedix, Inc. Common Stock as of Q1 2024.

Based on Thompson Davis & Co's 13F filing for Q1 2024, filed 2 May 2024.